The Association of Community Cancer Centers (ACCC) brings together cancer programs and practices united in commitment to advancing delivery and access to high-quality cancer care. ACCC understands the value patients place on receiving treatment in their home communities and supports its members and the entire oncology specialty in prioritizing equity, diversity, and inclusion in quality cancer care delivery and within the oncology workforce.
The U.S. Centers for Disease Control and Prevention defines health equity simply and clearly: Health equity is when everyone has the opportunity to be as healthy as possible.
Health equity is achieved when all individuals have the opportunity to reach their full health potential, and no one is held back from achieving this potential due to social position or other socially determined circumstances.
Across healthcare—and cancer care—we recognize the critical need to advance health equity to lessen and eliminate health disparities is recognized.
ACCC continues to develop resources and tools to better understand and support equity initiatives in cancer prevention and detection, diagnosis and treatment, access to clinical trials, survivorship and end-of-life care. Please continue to check this webpage for new updates on this important work.
The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships, establish clinical trials as a standard of care in treatment plans, and help achieve equitable cancer care delivery for all patients.
As the oncology community takes action to improve diversity and equity in cancer clinical research and care delivery, in spring 2021 ACCC and Harborside hosted a “Virtual Summit to Define the Role of Oncology Advanced Practitioners in Equitable Cancer Care Delivery.” Over three sessions, a select group of thought leaders, including oncology nurse practitioners, advanced degree nurses, physician assistants, oncology pharmacists, patient advocates, and other members of the multidisciplinary cancer care team discussed the role for APs in equitable care delivery.
Read Outcomes & Explore Resources
To help address disparities in cancer care, The Arizona Clinical Oncology Society (TACOS), Hawaii Society of Clinical Oncology (HSCO), and Texas Society of Clinical Oncology (TxSCO)—all Chapter Members of ACCC—will develop and implement a community-based educational initiative that identifies and addresses disparities among groups specific to each state’s population. This includes the American Indian population living off reservations and outside of the Indian Health Service in Arizona, Native Hawaiians and Pacific Islanders, and Texas' Latinx/Hispanic American population.
The program, called 3, 2, 1, Go! will task each state society with aggregating 3 “go-to” resources to advance equity in cancer care, making 2 recommendations to eliminate disparities in care, and identifying 1 major gap in care that the organization wants to address.
Visit the TACOS, HSCO, and TxSCO state society web pages for updates on this work.
The ACCC Eliminating Precision Medicine Disparities project is focused on understanding specific barriers and challenges to equal access to precision medicine among underserved patient communities.
An expert panel reviews currently available data on cancer care disparities, discusses the needs of disadvantaged populations, and shares practical solutions and methods for implementing bias training. (April 20, 2021)
Optimal care delivery changes from place to place—what works best for one location and patient population may not be ideal for another. The same applies to cancer research. Understanding the needs of your patient population is critical to trial design and implementation. How can you proactively involve your community in cancer research activities? (January 27, 2021)
Learn more about resources which already exist, successful models for pharmacist integration into oncology research teams, and the unique skills which pharmacists offer the interdisciplinary team. (October 30, 2020)
Learn how to identify key disparities in clinical trial access for patients with multiple myeloma and explore strategies that can help improve access for underserved communities. (October 21, 2020)
In this episode, we'll explore how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so.
In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.
Learn about the cultural and logistical barriers to end-of-life health equity and discover strategies that programs can implement to both address palliative care earlier in the care continuum and reduce health disparities.
We discuss how the legacy of racism in American healthcare continues to affect today’s research, and share strategies for cancer programs to effectively communicate with underrepresented and marginalized populations.
Discover what steps cancer programs can take to build trust with patients from marginalized and underrepresented groups and ensure a more equitable and accessible healthcare environment.
Explore the barriers and challenges that LGBTQ+ patients with cancer face, and how cancer programs can make their care more inclusive.
Learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioritized community engagement.
Learn how the Livestrong Cancer Institutes and Dell Medical School at the University of Texas at Austin are reaching out to young women in high school to generate interest in oncology.
Development of an actionable framework to address cancer care disparities in medically underserved populations in the United States: expert roundtable recommendations
Real-World Lessons from COVID-19: Driving Oncology Care Forward (2021-22)
Community Oncology Can Close the Gap in Cancer Research (2020-21)